论文部分内容阅读
目的观察舒降之治疗肾病综合征合并高脂血症的疗效。方法高肾病综合征合并高脂血症患者36例随机分为2组即治疗组与对照组,2组分别服用舒降之20～40mg,观察血脂改变情况与临床疗效。结果2组服药后均有明显调脂作用(P<0.05),其中治疗组调脂作用更强;治疗组的治疗疗效明显好于对照组(P<0.05)。结论舒降之治疗肾病综合症合并高脂血症安全有效,临床上应用推荐使用大剂量。
Objective To observe the therapeutic effect of Shu-zheng on nephrotic syndrome complicated with hyperlipidemia. Methods Thirty-six patients with hypernatremic syndrome and hyperlipidemia were randomly divided into two groups (treatment group and control group). The two groups were given 20 ~ 40 mg of dipyridamole respectively. The changes of blood lipid and clinical efficacy were observed. Results Both groups showed significant lipid-lowering effect (P <0.05), and the lipid-lowering effect of the treatment group was stronger. The therapeutic effect of the treatment group was significantly better than that of the control group (P <0.05). Conclusion Shuzheng the treatment of nephrotic syndrome with hyperlipidemia safe and effective, recommended for clinical use high-dose.